Omni Bio to Conduct New Human Clinical TrialsMarketWatch (press release)Novel discoveries made at the University of Colorado Denver indicate that AAT has the potential to address a variety of indications in the areas of diabetes, transplant rejection a…
UC Davis transplant surgeon uses minimally invasive technique for kidney donors – PressZoom (press release)
UC Davis transplant surgeon uses minimally invasive technique for kidney donorsPressZoom (press release)Whalen's single-port (or "single-site") nephrectomy is the latest development in minimally invasive procedures to safely extract a kid…
Bellini renal cell carcinoma: Diagnosis and treatment. A report of 7 cases … – UroToday
Bellini renal cell carcinoma: Diagnosis and treatment. A report of 7 cases …UroTodayThe diagnosis of CDC was made by a nephrectomy specimen in all cases. Demographic, clinical, pathological and survival data were gathered. They were five men and two …
Three Cleveland hospitals to collaborate in national heart failure research … – Plain Dealer
Plain DealerThree Cleveland hospitals to collaborate in national heart failure research …Plain DealerBy Brie Zeltner, The Plain Dealer Comstock Images Research at three local healthcare institutions will focus on heart failure, which affects more tha…
Researchers decry 'regressive attitude,' urge more consideration of seniors … – McKnight's Long Term Care News
Researchers decry 'regressive attitude,' urge more consideration of seniors …McKnight’s Long Term Care News“Anyone who can benefit from kidney transplantation should at least be given a chance,” Segev said. “We have this regressive atti…
Biogen Idec prepares for multiple launches in coming years – The Pharma Letter
Biogen Idec prepares for multiple launches in coming yearsThe Pharma Letter… which will both have data readouts this year. o Delivering the data readout from the first Phase III trial of dexpramipexole in ALS by year-end. o Continuing to advance the …
NICE rejects Sanofi's Jevtana, citing cancer drug's side effects – PMLiVE
NICE rejects Sanofi's Jevtana, citing cancer drug's side effectsPMLiVENICE's final draft guidance does not recommend Jevtana (cabazitaxel) in combination with prednisone or prednisolone in prostate cancer that had progressed despite treatme…
Device is life-giving after heart disease – The Tennessean
Device is life-giving after heart diseaseThe TennesseanI am one of 650000 Americans who are diagnosed with heart failure each year. I have fought a four-decade-long battle with the devastating effects of my long-term heart condition. My wife, Elsie, ca…
Islet Sciences chooses NeoStem unit for product manufacturing – Pharmaceutical Business Review
Proactive Investors USA & CanadaIslet Sciences chooses NeoStem unit for product manufacturingPharmaceutical Business ReviewAs per the deal, PCT will perform microencapsulation for parsing beta pancreatic islets for xenotransplantation using piglet panc…
Diverse SA must tap stem cells locally – Business Day
Diverse SA must tap stem cells locallyBusiness Day"Stem cell therapy, such as bone marrow transplantation for cancers like leukaemia, has been going on in SA for decades, but most South Africans are denied this treatment because there are not enou…